RedStone Secures $15 Million in Series A Funding to Propel Blockchain Innovation

Switzerland-based blockchain startup RedStone, originally founded in Poland, has successfully closed a $15 million Series A funding round led by Arrington Capital. This significant investment marks a pivotal moment for the company, known for its pioneering work in multichain databases and blockchain oracles. Founded in 2021 by Jakub Wojciechowski and Marcin Kazmierczak, RedStone has quickly…

Read More

eAgronom Secures €10M Series A2 to Expand Sustainable Agriculture Initiatives

eAgronom, a pioneering climate tech company based in Tallinn, Estonia, has successfully closed a €10 million Series A2 equity round led by Swedbank. This funding milestone marks a significant leap forward for eAgronom, empowering the company to bolster its sustainable agriculture programs and expand its footprint across key global markets. The announcement was made through…

Read More

OpenFi Secures €585k Pre-Seed Funding to Propel Expansion of Conversational AI Platform

OpenFi, a pioneering London-based conversational AI platform specializing in lead generation and customer nurture, has successfully closed a pre-seed funding round totaling €585k. The investment, spearheaded by Bijan Morvaridi and supported by Fortune Green Capital Ltd and Foundation Ventures Ltd, marks a significant milestone for the company as it accelerates plans for product enhancement and…

Read More

Rejuvenate Bio Secures $4M Funding from CIRM to Advance Breakthrough Gene Therapy for Rare Heart Condition

Rejuvenate Bio, a pioneering biotechnology firm specializing in gene therapies, announced today the reception of a $4 million grant from the California Institute for Regenerative Medicine (CIRM) to propel the development of its innovative gene therapy, RJB-0402, aimed at treating desmoplakin gene variant arrhythmogenic cardiomyopathy (DSP ACM). Desmoplakin gene variant arrhythmogenic cardiomyopathy (DSP ACM) is…

Read More
Dr. Mark Lee, M.D., Ph.D., N-Power Medicine

N-Power Medicine Raises $72M in Series B Funding to Advance Oncology Clinical Trials Platform

N-Power Medicine, a trailblazer in redefining the clinical trial landscape, has announced a significant milestone with the closure of its Series B funding round, securing $72 million in total funding. Led by the Merck Global Health Innovation Fund, alongside a prominent U.S.-based healthcare investor, this funding infusion marks a pivotal moment for N-Power Medicine as…

Read More

Unrivaled Excellence: Cognigy Secures Consecutive Win in AI Breakthrough Awards 2024

Cognigy, a pioneer in AI-driven customer service solutions, proudly announces its consecutive victory in the prestigious AI Breakthrough Awards 2024, clinching the title of “Best Natural Language Understanding Solution” for the second year running. Hosted by AI Breakthrough, a leading market intelligence firm, the annual awards program recognizes outstanding achievements in artificial intelligence across various…

Read More

Instructure Bolsters K-12 Credentialing with Scribbles Acquisition

Instructure Holdings, Inc. (NYSE: INST), a leading provider of learning management solutions, announced today the successful completion of its acquisition of Scribbles, a prominent K-12 credentialing and records management company based in Charlotte, North Carolina. This strategic move strengthens Instructure’s foothold in the K-12 space by expanding its credentialing network and bolstering its support for…

Read More

Anbogen Therapeutics Secures $7.3M to Propel ABT-301 Cancer Therapy to Phase II Trials

Anbogen Therapeutics, a leading name in cancer therapeutics development, has announced the successful completion of an oversubscribed A+ round financing, securing USD 7.3 million to advance their groundbreaking cancer treatment, ABT-301. This latest funding round follows on the heels of a USD 12.5 million Series A round earlier this year, bringing Anbogen’s total funding to…

Read More

Kanvas Biosciences Secures $12.5M to Propel Microbiome-Based Cancer Therapies

Kanvas Biosciences, a pioneering spatial biology company, has announced a significant stride in its mission to revolutionize healthcare with microbiome-based therapies. With an additional $12.5 million in funding co-led by DCVC and Lions Capital LLC, and supported by FemHealth Ventures, Germin8, Ki Tua Fund, and Pangaea Ventures, alongside existing investors, the company’s total funding now…

Read More

ISPTech Secures €2 Million to Propel Green Spacetech Innovation

InSpacePropulsion Technologies (ISPTech), a pioneering spin-off from the German Aerospace Center (DLR), has announced a significant milestone with a €2 million Pre-Seed funding round. This investment underscores ISPTech’s commitment to revolutionizing the space industry with its innovative green propulsion systems, designed to enhance performance, reliability, and affordability across a wide range of spacecraft applications. Founded…

Read More